A--Notice of Intent to Procure Via Sole Source Development and FDA Clearance or Approval of a Traumatic Brain Injury Diagnostic Assay Using Abbott Laboratories i-Stat(R) Device

The United States Army Medical Research Acquisition Activity (USAMRAA) is issuing an Intent to Procure via Sole Source the award of a cost type contract with Abbott Laboratories (Abbott) for the development and FDA clearance or approval of a Traumatic Brain Injury (TBI) diagnostic assay using the Abbott i-STAT(R) device and Banyan Biomarkers, UCHL1 and GFAP (protein biomarkers), for the screening of serum for the presence or absence of TBI. The estimated period of performance for this acquisition is a base year with four (4) option years for a total of five (5) years. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. Responsible, interested parties may identify their interest by submitting capability information by Tuesday, 28 August 2012 at 3:00 p.m. EDT in order to establish the ability of the responder to meet this requirement. A determination by the Government to not compete this proposed contract based upon responses to this notice is solely within the discretion of the Government; information received will be considered for the sole purpose of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs associated with responses to this notification. All inquiries must be submitted via e-mail to contact@example.gov. Telephonic inquiries will not be accepted.